| Model Number |
PED2-400-16 |
| Medical Device Problem Codes |
Retraction Problem (1536); Physical Resistance/Sticking (4012)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/29/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: marksman catheter product id fa-55150-1030 (lot 231338909).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received a report that after the marksman catheter was in place, the pipeline flex with shield technology stent was delivered, and the stent deployment process was smooth.However, after deploying the stent and when retracting the stent delivery rod, the distal end of the delivery rod could not be retracted into the distal catheter, resulting in the distal radiopaque marker and protective sleeve being outside the catheter.At this point, the surgeon could only withdraw both the catheter and the delivery rod together.Upon removal from the body, it was found that the catheter was severely deformed, and the stent delivery rod was outside the catheter, affecting intraoperative manipulation.No patient symptoms or complications were associated with this event.The patient was undergoing surgery for treatment of an intracranial aneurysm.It was noted the patient's vessel tortuosity was normal.Right femoral artery access vessel diameter was 7.2 mm.The reported device and any accessory devices were prepared, and the catheter was flushed, as indicated in the instructions for use (ifu).
|
| |
|
Additional Manufacturer Narrative
|
|
Update: b5.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received.The patient was treated for ophthalmic artery aneurysm, 4.3 × 2.6 × 2 mm; irregular aneurysm, right side, 4.3 × 2.6 × 2 mm).The cause of the resistance was not determined, and the cause of the catheter damage was also not determined.A continuous saline flush was administered and maintained in accordance with the ifu.No damage to the pipeline pushwire was observed.
|
| |
|
Search Alerts/Recalls
|